Anavex Life Sciences Corp. Ratios

Ratios Sep2009 Sep2010 Sep2015 Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024
Profitability
FCF Margin 5,354.67%1,156.64%
Valuation
Enterprise Value 217.30M167.95M174.59M124.03M166.38M273.87M1,358.95M804.37M536.78M481.64M
Market Capitalization 273.87M1,358.95M804.37M536.78M481.64M